Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MURRAY FERSHTMAN M.D. P.A.

NPI: 1205218492 · MONTGOMERY, TX 77356 · Pediatrics Physician · NPI assigned 06/24/2015

$716K
Total Medicaid Paid
23,800
Total Claims
18,370
Beneficiary Records
36
Codes Billed
2020-10
First Month
2024-12
Last Month

Provider Details

Authorized OfficialFERSHTMAN, MURRAY (OWNER/PRESIDENT)
NPI Enumeration Date06/24/2015

Related Entities

Other providers sharing the same authorized official: FERSHTMAN, MURRAY

ProviderCityStateTotal Paid
MURRAY B. FERSHTMAN, M.D. CONROE TX $78K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 1,465 $31K
2021 7,735 $210K
2022 6,782 $224K
2023 4,812 $161K
2024 3,006 $89K

Billing Codes

CodeDescriptionClaimsBene. RecordsTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,959 3,535 $197K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4,579 3,902 $164K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1,052 949 $78K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 674 627 $54K
90460 Immunization administration through 18 years of age via any route, first or only component 5,006 2,198 $50K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 444 416 $34K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 416 396 $32K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 258 248 $23K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 398 371 $19K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,067 990 $14K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 315 292 $12K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1,204 782 $9K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 243 194 $8K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 491 198 $6K
90461 1,107 875 $5K
99215 Prolong outpt/office vis 43 42 $3K
S8301 Infection control supplies, not otherwise specified 335 309 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 66 61 $2K
97169 58 56 $2K
87634 21 19 $1K
87807 46 42 $489.38
99072 185 164 $178.50
90686 548 516 $19.78
96160 14 13 $14.52
90670 394 372 $0.00
90707 114 104 $0.00
90633 94 86 $0.00
90671 25 25 $0.00
90734 46 38 $0.00
90716 113 104 $0.00
90680 103 98 $0.00
90744 61 55 $0.00
96127 149 130 $0.00
90698 146 137 $0.00
90697 14 14 $0.00
90651 12 12 $0.00